• TuHURA Biosciences drew USD 1.9 million on June 30, 2026 under a revolving credit facility with Parkview Holdings One.
• The facility, signed April 21, 2026, provides up to USD 50 million in borrowing capacity.
• The revolver matures April 21, 2031.
• Proceeds are expected to fund general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tuhura Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-297668), on July 07, 2026, and is solely responsible for the information contained therein.